Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Newland JG et al. - Since terbinafine was introduced on the world market 17 years ago, it has become the leading antifungal for the treatment of superficial fungal infections, aided by unique pharmacologic and microbiologic profiles.


Related Articles

Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
British Journal of Dermatology, 10/07/09    Relevance Score: 84%

Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis
Journal of the European Academy of Dermatology and Venereology, 10/26/09    Relevance Score: 83%

Terbinafine: a pharmacological and clinical review
Expert Opinion in Pharmacotherapy, 11/03/09    Relevance Score: 82%

In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis
Clinical and Experimental Dermatology, 11/02/09    Relevance Score: 82%

Today in Derm Infectious Disease...keeping you current

A Randomized Controlled Trial of Local Heat Therapy Versus Intravenous Sodium Stibogluconate for the Treatment of Cutaneous Leishmania major Infection
PLoS Neglected Tropical Diseases, 03/15/10

Coexistence of papulonecrotic tuberculide with lichen scrofulosorum
Indian Journal of Dermatology, 03/15/10

Candidate gene study of susceptibility to cutaneous leishmaniasis in Sri Lanka
Tropical Medicine & International Health, 03/15/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address